BridgeBio Oncology Therapeutics Inc. share price logo

BridgeBio Oncology Therapeutics Inc.

NASDAQ: BBOT

Small Cap

$9.23

+0.03

(+0.33%)

Live

as on

BridgeBio Oncology Therapeutics Inc. Stock Performance

as on August 13, 2026 at 3:06 am IST

  • Day's Low

    Day's High

    $9.07
    $9.30
    downward going graph

    1.73%

    Downside

    0.76%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.00
    $14.87
    downward going graph

    24.16%

    Downside

    61.11%

    Upside

    downward going graph

BridgeBio Oncology Therapeutics Inc. share price movements today

Previous Close
$9.20
Open
$9.07
Volume
71.3K
Day's Low - High
$9.07 - $9.30
52 Week Low - High
$7.00 - $14.87

BridgeBio Oncology Therapeutics Inc. Historical Returns

1 Month Return
+ 10.58 %
3 Month Return
+ 13.16 %
1 Year Return
-4.66 %
3 Year Return
0 %
5 Year Return
0 %

BridgeBio Oncology Therapeutics Inc. Stock Fundamentals & Key Indicators

Check BridgeBio Oncology Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$743.4M

EPS (TTM)

-2.2126

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-62.21%

BridgeBio Oncology Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BridgeBio Oncology Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BridgeBio Oncology Therapeutics Inc. image
BridgeBio Oncology Therapeutics Inc.
NA$743.4MNANA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$44.4B758.25%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$132.8B171.88%28.935.00%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$83.2B31.09%19.4227.87%0.45999999999999996%

Stock Returns calculator for BridgeBio Oncology Therapeutics Inc. Stock including INR - Dollar returns

The BridgeBio Oncology Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

BridgeBio Oncology Therapeutics Inc. investment value today

Current value as on today

₹1,04,070

Returns

₹4,070

(+4.07%)

Returns from BridgeBio Oncology Therapeutics Inc. Stock

-₹4,352 (-4.35%)

Dollar Impact

₹8,422 (+8.42%)

Indian Investors' Interest in BridgeBio Oncology Therapeutics Inc. Stock

Search interest for BridgeBio Oncology Therapeutics Inc. Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:26% versus previous 30 day period

BridgeBio Oncology Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
0
-
-
-
-
0
0
Operating Income
-15
-23
-19
-21
-23
-30
-49
-43
-46
EBITDA
-15
-23
-19
-21
-23
-29
-49
-43
-45
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-15
-21
-17
-19
-22
-28
-44
-38
-42
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-15
-21
-17
-19
-22
-28
-44
-38
-42
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

BridgeBio Oncology Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
Gross Profit
-
-
0
Operating Income
-64
-80
-145
EBITDA
-64
-80
-145
Interest Expense
-
-
-
Depreciation
0
0
0
Income Before Tax
-64
-74
-134
Income Tax Expense
-
-
-
Net Income
-64
-74
-134
Net Profit Margin
0.00%
0.00%
0.00%

BridgeBio Oncology Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-15
2
-17
1
0
-28
-44
-38
-42
Operating Cash Flow
-8
0
-39
0
0
-23
-70
-42
-35
Investing Cash Flow
2
-
37
-
-
9
65
7
-285
Financing Cash Flow
6
199
19
0
0
18
383
0
0
Change in Cash
0
0
0
0
0
5
408
-35
-321

BridgeBio Oncology Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
7
-134
Operating Cash Flow
-
-52
0
-113
Investing Cash Flow
-
-
-184
73
Financing Cash Flow
-
55
186
383
Change in Cash
-
0
1
342

Global Institutional Holdings in BridgeBio Oncology Therapeutics Inc.

Funds
Holdings
EcoR1 Capital, LLC
3.52%
BlackRock Inc
2.61%
Adage Capital Partners Gp LLC
0.5%
Cormorant Asset Management, LLC
22.32%
Deerfield Management Co
6.1%
See all

Insights on BridgeBio Oncology Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BBOT stock has moved up by 10.6%

About BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of small-molecule therapeutics for the treatment of renin-angiotensin system and phosphoinositide 3-kinase malignancies in the United States. The company develops BBO-8520, an orally bioavailable small molecule direct inhibitor, which is in Phase I clinical trial for the treatment of patients with KRASG12C mutant non-small cell lung cancer; and BBO-11818, an orally bioavailable small molecule pan-KRAS inhibitor, which is in Phase I clinical trial for the treatment of patients with KRAS G12D and KRAS G12V cell-derived xenograft models. It is also involved in the development of BBO-10203, an orally bioavailable small molecule, which is in Phase I clinical trial for the treatment of patients with HER2+ breast cancer, HR+/HER2- breast cancer, KRAS mutant colorectal cancer, and KRAS mutant non-small cell lung cancer; and precision oncology assets for patients with tumors. The company was incorporated in 2016 is headquartered in South San Francisco, California.
OrganisationBridgeBio Oncology Therapeutics Inc.
Headquarters256 East Grand Avenue, South San Francisco, CA, United States, 94080
IndustryBiotechnology
CEODr. Pedro J. Beltran M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of BridgeBio Oncology Therapeutics Inc.

Name

Title

Dr. Frank P. McCormick Ph.D.

Co-Founder, Non-Executive Director & Chair of the Advisory Board

Dr. Pedro J. Beltran M.D., Ph.D.

Chief Executive Officer and Director

Mr. Aaron Chan J.D.

Vice President of Legal

Mr. Bin Wang Ph.D.

Senior Vice President of Drug Discovery

Mr. Daniel Watson Ph.D.

Senior Vice President of Chemistry, Manufacturing & Controls

Mr. Rui Xu Ph.D.

Senior Vice President of Drug Discovery

Dr. Neil Kumar Ph.D.

Executive Chairman

Dr. Yong Ben M.B.A., M.D.

Chief Medical & Development Officer

Mr. Marc Cobo

VP of Finance & Controller

Mr. Idan Elmelech M.A., M.B.A.

Chief Operating Officer

FAQs

What is BridgeBio Oncology Therapeutics Inc. share price today?

BridgeBio Oncology Therapeutics Inc. share price today is $9.23 as on . BridgeBio Oncology Therapeutics Inc. share today touched a day high of $9.30 and a low of $9.07.

What is the 52 week high and 52 week low for BridgeBio Oncology Therapeutics Inc. share?

BridgeBio Oncology Therapeutics Inc. share touched a 52 week high of $14.87 on and a 52 week low of $7.00 on . BridgeBio Oncology Therapeutics Inc. stock price today i.e. is trending at $9.23,which is 37.93% down from its 52 week high and 31.86% up from its 52 week low.

What is BridgeBio Oncology Therapeutics Inc.'s market capitalisation today?

BridgeBio Oncology Therapeutics Inc. market capitalisation is $0.00T as on .

How to invest in BridgeBio Oncology Therapeutics Inc. Stock (BBOT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BridgeBio Oncology Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BridgeBio Oncology Therapeutics Inc. Shares that will get you 0.1625 shares as per BridgeBio Oncology Therapeutics Inc. share price of $9.23 per share as on August 12, 2026 at 9:36 pm IST.

What is the minimum amount required to buy BridgeBio Oncology Therapeutics Inc. Stock (BBOT) from India?

Indian investors can start investing in BridgeBio Oncology Therapeutics Inc. (BBOT) shares with as little as ₹95.32 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.20 in BridgeBio Oncology Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on BridgeBio Oncology Therapeutics Inc. share’s latest price of $9.23 as on August 12, 2026 at 9:36 pm IST, you will get 1.0834 shares of BridgeBio Oncology Therapeutics Inc.. Learn more about fractional shares .